← SynDRA
S-15535
SynDRA canonical compound SYN1964519 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | HTR1A |
|---|
| Mechanism of action | serotonin receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- serotonin receptor agonist
- HTR1A ANTAGONIST
Cross-references
- PubChem CID: 132787
- TTD: D0P2QO
Synonyms
- S 15535
- 4-(Benzodioxan-5-yl)-1-(indan-2-yl)piperazine
- S15535
- 1-(2,3-Dihydro-1,4-benzodioxin-5-yl)-4-(2,3-dihydro-1h-inden-2-yl)-piperazine
- 1-(2,3-dihydro-1H-inden-2-yl)-4-(2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperazine
- Piperazine,1-(2,3-dihydro-1,4-benzodioxin-5-yl)-4-(2,3-dihydro-1H-inden-2-yl)-
- 1-(2,3-dihydro-1,4-benzodioxin-8-yl)-4-(2,3-dihydro-1H-inden-2-yl)piperazine
- PDSP1_000559
- ACMC-20ehn1
- [3H]S-15535
- GTPL26
- GTPL32
- AC1L31KI
- CHEMBL49247
- SCHEMBL1650175
- CTK4C5212
- BDBM82564
- ZINC16050
- 1-(1,4-Benzodioxan-5-yl)-4-(indan-2-yl)piperazine
Look up S-15535 in the interactive SynDRA portal →